Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Biebermann, H.
Right arrow Articles by Grüters, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Biebermann, H.
Right arrow Articles by Grüters, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:2984-2988, 2003
© 2003 by the American Diabetes Association, Inc.

Autosomal-Dominant Mode of Inheritance of a Melanocortin-4 Receptor Mutation in a Patient with Severe Early-Onset Obesity Is Due to a Dominant-Negative Effect Caused by Receptor Dimerization

Heike Biebermann1, Heiko Krude1, Andrea Elsner1, Vladimir Chubanov2, Thomas Gudermann2, and Annette Grüters1

1 Otto Heubner Centrum für Kinderheilkunde und Jugendmedizin, Pädiatrische Endokrinologie, Charité Campus Virchow-Klinikum, Humboldt-Universität zu Berlin, Berlin, Germany
2 Institut für Pharmakologie und Toxikologie, Philipps-Universität Marburg, Marburg, Germany

Mutations in the melanocortin-4 receptor (MC4R) gene are the most frequent monogenic causes of severe obesity. Most mutations have been described as heterozygous with loss of function, suggesting that haploinsufficiency is the most likely mechanism of dominant inheritance. We detected a heterozygous mutation, D90N, in a patient with severe early-onset obesity. Functional characterization of the mutant receptor revealed normal cell-surface expression and binding properties but loss of signal transduction activity. In coexpression studies of wild-type (WT)-MC4R and D90N, the mutant receptor had a dominant-negative effect on WT-receptor function. Further investigation of this effect with sandwich enzyme-linked immunosorbent assays and fluorescence resonance energy transfer studies showed that the WT-MC4R and the D90N mutant form homodimers and heterodimers. We hypothesize that the dominant-negative effect of the D90N mutation is caused by a functionally altered WT-MC4R/D90N receptor heterodimer. These findings necessitate the reinvestigation of other heterozygous MC4R missense mutations to discriminate between haploinsufficiency and a dominant-negative effect. The finding of receptor dimerization highlights a more complex hypothalamic signaling network governing the regulation of body weight.


Address correspondence and reprint requests to Dr. Heike Biebermann, Otto Heubner Centrum für Kinderheilkunde und Jugendmedizin, Pädiatrische Endokrinologie, Charité Campus Virchow-Klinikum, Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353 Berlin, Germany. E-mail: heike.biebermann{at}charite.de


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
K. A. Beaumont, S. L. Shekar, R. A. Newton, M. R. James, J. L. Stow, D. L. Duffy, and R. A. Sturm
Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles
Hum. Mol. Genet., September 15, 2007; 16(18): 2249 - 2260.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Hinney, T. Bettecken, P. Tarnow, H. Brumm, K. Reichwald, P. Lichtner, A. Scherag, T. T. Nguyen, P. Schlumberger, W. Rief, et al.
Prevalence, Spectrum, and Functional Characterization of Melanocortin-4 Receptor Gene Mutations in a Representative Population-Based Sample and Obese Adults from Germany
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1761 - 1769.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y.-X. Tao and D. L. Segaloff
Functional Analyses of Melanocortin-4 Receptor Mutations Identified from Patients with Binge Eating Disorder and Nonobese or Obese Subjects
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5632 - 5638.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
H. Biebermann, P. Ambrugger, P. Tarnow, A. von Moers, U. Schweizer, and A. Grueters
Extended clinical phenotype, endocrine investigations and functional studies of a loss-of-function mutation A150V in the thyroid hormone specific transporter MCT8
Eur. J. Endocrinol., September 1, 2005; 153(3): 359 - 366.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. H. Larsen, S. M. Echwald, T. I. A. Sorensen, T. Andersen, B. S. Wulff, and O. Pedersen
Prevalence of Mutations and Functional Analyses of Melanocortin 4 Receptor Variants Identified among 750 Men with Juvenile-Onset Obesity
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 219 - 224.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L. Ma, P. A. Tataranni, C. Bogardus, and L. J. Baier
Melanocortin 4 Receptor Gene Variation Is Associated With Severe Obesity in Pima Indians
Diabetes, October 1, 2004; 53(10): 2696 - 2699.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
A Dempfle, A Hinney, M Heinzel-Gutenbrunner, M Raab, F Geller, T Gudermann, H Schafer, and J Hebebrand
Large quantitative effect of melanocortin-4 receptor gene mutations on body mass index
J. Med. Genet., October 1, 2004; 41(10): 795 - 800.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.